Evaluation of a self-administered oral glucose tolerance test.

Evaluation of a self-administered oral glucose tolerance test.

Show other versions (1)

OBJECTIVE: To assess the feasibility of using a disposable, self-administered, capillary blood sampling oral glucose tolerance test (OGTT) device in a community setting. RESEARCH DESIGN AND METHODS: Eighteen healthy and 12 type 2 diabetic volunteers underwent six 75-g OGTTs using a prototype device...

Full description

Bibliographic Details
Main Authors:	Bethel, M, Price, H, Sourij, H, White, S, Coleman, R, Ring, A, Kennedy, I, Tucker, L, Holman, R
Format:	Journal article
Language:	English
Published:	American Diabetes Association 2013

Similar Items

Evaluation of a self-administered oral glucose tolerance test
by: Bethel, M, et al.
Published: (2013)

High Frequency of Unrecognized Diabetes in Cardiovascular Patients: Should All Have an Oral Glucose Tolerance Test?
by: Bethel, M, et al.
Published: (2008)

Adding value to the experience of attending a diabetes clinic appointment: provision of personalised 10 year cardiovascular disease (CVD) risk estimates
by: Adamson, R, et al.
Published: (2013)

Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
by: Bethel, M, et al.
Published: (2016)

Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
by: Fuchs D, et al.
Published: (2012-02-01)

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
by: Holman, R, et al.
Published: (2014)

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
by: Holman, R, et al.
Published: (2014)

GLUCOSE-TOLERANCE AND BETA-CELL FUNCTION ASSESSED BY CONTINUOUS INFUSION OF GLUCOSE AND ORAL GLUCOSE-TOLERANCE TEST
by: Levy, J, et al.
Published: (1992)

ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
by: YiHong, S, et al.
Published: (2013)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
by: Currie, G, et al.
Published: (2017)

Abnormal glucose tolerance in children: oral glucose tolerance test is fit-for-purpose
by: Vivian Yuet Ho Law, et al.
Published: (2023-04-01)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
by: Califf, R, et al.
Published: (2008)

The Oral Glucose Tolerance Test: 100 Years Later
by: Jagannathan R, et al.
Published: (2020-10-01)

Study of glucose homeostasis in burnout cases using an oral glucose tolerance test
by: Anna-Karin Lennartsson, et al.
Published: (2025-12-01)

Glimepiride Administered in Chow Reversibly Impairs Glucose Tolerance in Mice
by: Dana M. Niedowicz, et al.
Published: (2018-01-01)

Evaluation of patient satisfaction following oral glucose tolerance test
by: Püren Gökbulut, et al.
Published: (2024-04-01)

A standardized triglyceride and carbohydrate challenge: the oral triglyceride tolerance test.
by: Mohanlal, N, et al.
Published: (2004)

Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach
by: Theodorakis, M, et al.
Published: (2016)

Measurement of breath acetone in patients referred for an oral glucose tolerance test
by: Andrews, B, et al.
Published: (2018)

Maximum tolerated dose and toxicity evaluation of orally administered docetaxel granule in mice
by: Xiaowei Dong, et al.
Published: (2024-06-01)

Nonlinear modeling of oral glucose tolerance test response to evaluate associations with aging outcomes.
by: Grant Schumock, et al.
Published: (2024-01-01)

Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice
by: Bethel, A, et al.
Published: (2011)

Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice.
by: Bethel, M, et al.
Published: (2012)

Identification of Glucagon Secretion Patterns during an Oral Glucose Tolerance Test
by: Andrew Shahidehpour, et al.
Published: (2023-07-01)

ANTENATAL FACTORS AFFECTING THE DECISION TO HAVE AN ORAL GLUCOSE TOLERANCE TEST
by: Ezgi Doğan Tekbaş, et al.
Published: (2023-01-01)

Does prior exercise affect oral glucose tolerance test results?
by: Davis James, et al.
Published: (2008-09-01)

Effects of fructose added to an oral glucose tolerance test on plasma glucose excursions in healthy adults
by: Amée M. Buziau, et al.
Published: (2023-06-01)

Prolonged plasma glucose elevation on oral glucose tolerance test in young healthy Japanese individuals
by: Hirotaka Ishigaki, et al.
Published: (2020-01-01)

10-year follow-up of intensive glucose control in type 2 diabetes.
by: Holman, R, et al.
Published: (2008)

Women develop diabetes at higher BMIs than men.
by: Sourij, H, et al.
Published: (2012)

Women develop diabetes at higher BMIs than men
by: Sourij, H, et al.
Published: (2012)

Safety, tolerability and toxicokinetics of the novel mitochondrial drug SUL-138 administered orally to rat and minipig
by: Daniël H. Swart, et al.
Published: (2024-06-01)

Prevalence of diabetes mellitus and impaired glucose tolerance in patients with decompensated cirrhosis being evaluated for liver transplantation: the utility of oral glucose tolerance test
by: Ana Carolina Costa Bragança, et al.
Published: (2010-03-01)

A disposable, self-administered electrolyte test
by: Prince, Ryan, 1977-
Published: (2005)

Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans
by: Nakanishi S, et al.
Published: (2013-11-01)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
by: Krum, H, et al.
Published: (2010)

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
by: Latini, R, et al.
Published: (2013)

The Glycemic Curve during the Oral Glucose Tolerance Test: Is It Only Indicative of Glycoregulation?
by: Daniela Vejrazkova, et al.
Published: (2023-04-01)

Acromegaly with initial negative oral glucose tolerance test: a case report
by: Wen-Hsuan Tsai, et al.
Published: (2023-08-01)

Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes
by: Paul Harrison, et al.
Published: (2019-05-01)